SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-319104
Filing Date
2013-08-05
Accepted
2013-08-05 16:13:33
Documents
4
Period of Report
2013-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d580736d8k.htm 8-K 17498
2 EX-10.1 d580736dex101.htm EX-10.1 69806
3 EX-99.1 d580736dex991.htm EX-99.1 59756
4 GRAPHIC g580736ex99_1pg001.jpg GRAPHIC 28182
  Complete submission text file 0001193125-13-319104.txt   187403
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23155 | Film No.: 131010415
SIC: 2836 Biological Products, (No Diagnostic Substances)